依托泊苷
医学
拓扑替康
养生
化疗
肿瘤科
骨髓
内科学
肺癌
药品
骨髓抑制
癌症
药理学
作者
Diane S. Aschenbrenner
标识
DOI:10.1097/01.naj.0000753640.11029.39
摘要
Trilaciclib (Cosela) is approved to protect normal bone marrow cells from damage secondary to chemotherapy in adults receiving a platinum–etoposide chemotherapy regimen or a topotecan chemotherapy regimen for extensive-stage small cell lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI